S29 - Cerebrovascular Disease and Interventional Neurology: Critical Care and Hemorrhage

Event Time: Wednesday April 26, 2017 1:00 pm to 3:00 pm
Topic(s): Cerebrovascular Disease and Interventional Neurology
Description: A group of abstracts covering a similar topic presented in an oral format. Presentations are eight minutes in length with four minutes of question and answer. Each session concludes with 25 minutes of a discussant bringing additional context to one or more of the abstracts.
Completion Message:
CME Credits: 2
Core Competencies:

Abstract Presenters

Start Time Pub. Title Presenter
1:00 PM 001 Oral anticoagulation is a significant risk factor for spontaneous primary intraventricular hemorrhage Bhaskar Roy, MD
Dr. Roy has nothing to disclose.

1:12 PM 002 Ten-year temporal trends in medical complications following acute intracerebral hemorrhage in the United States Fadar Otite, MD
Dr. Otite has nothing to disclose.

1:24 PM 003 The therapeutic benefit of systolic blood pressure lowering may be obscured in intent to treat analysis due to lack of achieving therapeutic systolic blood pressure targets in a proportion of randomized subjects Antihypertensive Treatment of Acute Cerebral Hemorrhage II Investigators
Dr. Hemorrhage II Investigators has nothing to disclose.

1:36 PM 004 Temporal trends in medical complications and mortality following subarachnoid hemorrhage in the United States from 2004-2013 Ashutosh Mahapatra, MD
Dr. Mahapatra has nothing to disclose.

1:48 PM 005 National Estimates of Recurrent Intracranial Hemorrhage among Patients with Ruptured Intracranial Aneurysms: Effect of Treatment Modality Saqib Chaudhry, MD
Dr. Chaudhry has nothing to disclose.

2:00 PM 006 Radiographic Predictors of Prognosis In Intracerebral Hemorrhage: “If It Ain′t Broke, Don′t Fix It” Amanda Pennington, MD
Dr. Pennington has nothing to disclose.

2:12 PM 007 Early Surgery for Infective Endocarditis with Stroke Does Not Increase Post-operative Neurological Complications: What are We Waiting For? Lucy Zhang, MD
Dr. Zhang has nothing to disclose.

2:24 PM 008 Long Term Outcomes of IV Glyburide In Patients 70 Years of Age or Under: Subgroup Analysis from the Phase II GAMES-RP Study of Patients with Large Hemispheric Infarction Kevin Sheth, MD, FAAN
Dr. Sheth has nothing to disclose.

Register Now

Related Courses